Literature DB >> 22263715

Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort.

Andiea Harris1, Daniel Selling, Charles Luther, Jason Hershberger, Joan Brittain, Samuel Dickman, Alvin Glick, Joshua D Lee.   

Abstract

The Rikers Island Key Extended Entry Program (KEEP) has offered methadone treatment for opioid dependent inmates incarcerated in New York City's jails since 1986. In response to a trend toward low-dose methadone maintenance prescribing, a quality improvement (QI) protocol trained KEEP counselors, physicians, and pharmacists in the evidence base supporting moderate-to-high methadone maintenance doses in order to maximize therapeutic effects and rates of successful reporting to community methadone treatment programs (MTPs) post release. Discharge dose level and length of incarceration data were analyzed for 2 groups of KEEP patients discharged pre/post-QI. Among patients incarcerated for 21 or more days, the proportion of those on moderate-to-high doses of methadone increased significantly. Patients who reached a moderate-to-high methadone dose demonstrated higher rates of reporting to community MTP versus lower doses, both pre- and post-QI. Overall, a higher proportion of all patients reported to community MTP post-QI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22263715     DOI: 10.1080/08897077.2011.620479

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  8 in total

1.  Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.

Authors:  Jeffrey A Wickersham; Muhammad Muhsin Zahari; Marwan M Azar; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2013-02-13       Impact factor: 4.492

2.  A randomized trial of methadone initiation prior to release from incarceration.

Authors:  Michelle McKenzie; Nickolas Zaller; Samuel L Dickman; Traci C Green; Amisha Parihk; Peter D Friedmann; Josiah D Rich
Journal:  Subst Abus       Date:  2012       Impact factor: 3.716

3.  Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite study.

Authors:  Archana Krishnan; Jeffrey A Wickersham; Ehsan Chitsaz; Sandra A Springer; Alison O Jordan; Nick Zaller; Frederick L Altice
Journal:  AIDS Behav       Date:  2013-10

4.  Extended-release naltrexone opioid treatment at jail reentry (XOR).

Authors:  Ryan D McDonald; Babak Tofighi; Eugene Laska; Keith Goldfeld; Wanda Bonilla; Mara Flannery; Nadina Santana-Correa; Christopher W Johnson; Neil Leibowitz; John Rotrosen; Marc N Gourevitch; Joshua D Lee
Journal:  Contemp Clin Trials       Date:  2016-05-10       Impact factor: 2.226

5.  Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.

Authors:  Josiah D Rich; Michelle McKenzie; Sarah Larney; John B Wong; Liem Tran; Jennifer Clarke; Amanda Noska; Manasa Reddy; Nickolas Zaller
Journal:  Lancet       Date:  2015-05-28       Impact factor: 79.321

6.  "I Kicked the Hard Way. I Got Incarcerated." Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments.

Authors:  Jeronimo A Maradiaga; Shadi Nahvi; Chinazo O Cunningham; Jennifer Sanchez; Aaron D Fox
Journal:  J Subst Abuse Treat       Date:  2015-11-25

Review 7.  Treating substance use disorders in the criminal justice system.

Authors:  Steven Belenko; Matthew Hiller; Leah Hamilton
Journal:  Curr Psychiatry Rep       Date:  2013-11       Impact factor: 5.285

8.  Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail.

Authors:  Joshua D Lee; Mia Malone; Ryan McDonald; Anna Cheng; Kumar Vasudevan; Babak Tofighi; Ann Garment; Barbara Porter; Keith S Goldfeld; Michael Matteo; Jasdeep Mangat; Monica Katyal; Jonathan Giftos; Ross MacDonald
Journal:  JAMA Netw Open       Date:  2021-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.